Aspire-Lakewood Holdings, Inc. develops pharmaceutical delivery technology, and designs and manufactures automotive and industrial control systems. The company creates improved formulations of existing pharmaceutical compounds using a nano-technology-based sublingual delivery system designed to enhance medication efficacy and reduce time to therapeutic effect. Its technology enables rapid absorption through under-the-tongue administration, allows medications to bypass hepatic metabolism to improve dose management and bioavailability. The company applies its delivery technology across therapeutic categories including analgesics, pain management and inflammation therapeutics, erectile dysfunction treatments, and traumatic brain injury drugs. Its product offerings include a sublingual aspirin formulation developed using its delivery technology. Its automotive and industrial control system products include mechatronic actuators, human machine interfaces, industrial cables, and cable control systems. Aspire-Lakewood Holdings, Inc. was formerly known as Aspire Biopharma Holdings, Inc. and changed its name to Aspire-Lakewood Holdings, Inc. in September 2026. Aspire-Lakewood Holdings, Inc. was incorporated in 2021 and is based in Estero, Florida.